Tagged: manhattan street capital

July 14, 2020 @ 3:45 pm By JD Alois  |  

Manhattan Street Capital, best known for its Reg A+ securities offerings, is pitching shares in Impossible Foods, a competitor to Beyond Meat (NASDAQ:BYND). As you probably know, Beyond Meat went public in mid-2019 raising about $240 million on a valuation of $1.5 billion. Shares were… Read More

November 6, 2019 @ 3:48 pm By JD Alois  |  

Manhattan Street Capital has circulated an email that outlines the cost of doing a Reg A+ securities offering. While I know not everyone may agree with their analysis, Manhattan Street Capital is a platform that facilitates Reg A+ offerings and thus has some boots on… Read More

December 4, 2018 @ 10:15 pm By JD Alois  |  

InSitu Biologics is reporting that it has topped $2 million using the Reg A+ crowdfunding exemption. The company anticipates reaching $10 million in equity capital as the campaign continues into 2019. InSitu Biologics is a biotech firm that claims positive initial results in pre-clinical studies… Read More

August 29, 2017 @ 11:25 am By JD Alois  |  

Manhattan Street Capital (MSC) has launched “ManhattanStreet-ICO”program for crowdfunding companies. The platform also said it will now accept cryptocurrency for issuers using Reg A+ and Reg D offerings. Several other investment crowdfunding platforms have recently announced their intent to facilitate ICOs. The shift by Manhattan… Read More

December 7, 2016 @ 9:35 am By JD Alois  |  

Manhattan Street Capital has entered the Reg A+ crowdfunding space with its first offer for Blue Marble Biomaterials. The platforms is accepting investor indications of interest now. Manhattan Street Capital has positioned its platform as a Reg A+ specialist. This updated securities exemption was created… Read More